Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 26Pain, Postoperative 17Neoplasms 13Lung Neoplasms 12Brain Neoplasms 12Depression 7Carcinoma, Hepatocellular 7Pain 6Colonic Neoplasms 6Thyroid Neoplasms 5Stomach Neoplasms 5Prostatic Neoplasms 5Leiomyoma 5Head and Neck Neoplasms 5Agnosia 5Ovarian Neoplasms 4Multiple Myeloma 4Delirium 4Colorectal Neoplasms 4Anxiety Disorders 4Supratentorial Neoplasms 3Rectal Neoplasms 3Pancreatic Neoplasms 3Myofibroma 3Lymphoma 3Hemorrhage 3Fatigue 3Emergence Delirium 3Chronic Pain 3Carcinoma, Non-Small-Cell Lung 3

Interventions

Radiotherapy 4Paclitaxel 4Carboplatin 4Sodium Chloride 3Oxaliplatin 3Cyclophosphamide 3Vincristine 2Surveys and Questionnaires 2Procarbazine 2Prednisolone 2Methotrexate 2Mental Status and Dementia Tests 2Magnetic Resonance Spectroscopy 2Magnesium Sulfate 2Leucovorin 2Duloxetine Hydrochloride 2Doxorubicin 2Dexamethasone 2Cytarabine 2Calcium Gluconate 2Amifostine 2Acupuncture Therapy 2neurotropin 1motexafin gadolinium 1haloperidol decanoate 1glutamic acid diethyl ester 1glucarpidase 1fludarabine phosphate 1fludarabine 1axicabtagene ciloleucel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Neurotoxicity Syndromes × Saline Solution × Clear all
NCT01882621 2016-06-01

Monosialoganglioside(GM1) Preventing Neurotoxicity Induced by Cisplatin Contained Chemotherapy in NSCLC Patients

Sun Yat-sen University

Phase 3 Unknown
300 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡